InMed Pharmaceuticals Inc...

NASDAQ: INM · Real-Time Price · USD
2.32
-0.02 (-0.85%)
At close: Aug 15, 2025, 3:59 PM
2.32
0.00%
After-hours: Aug 15, 2025, 04:00 PM EDT

InMed Pharmaceuticals Cash Flow Statement

Financials in USD. Fiscal year is July - June.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Jun 30, 2024 Jun 30, 2023 Jun 30, 2022 Jun 30, 2021
Net Income
-7.68M -7.95M -18.6M -10.2M
Depreciation & Amortization
604.52K 596K 511.79K 120.87K
Stock-Based Compensation
137.71K 278.15K 697.89K 610.19K
Other Working Capital
-435.56K 16.17K -687.51K -490.65K
Other Non-Cash Items
316.82K -803 4.46M 374.23K
Deferred Income Tax
n/a 356.89K n/a -242.39K
Change in Working Capital
-369.34K -565.82K -2.73M -450.45K
Operating Cash Flow
-6.99M -7.28M -15.58M -9.79M
Capital Expenditures
-9.29K -161.8K -39.11K -1.73K
Cash Acquisitions
n/a -500K -208.89K n/a
Purchase of Investments
-42.08K -42.27K -425K n/a
Sales Maturities Of Investments
42.08K 42.27K 425K n/a
Other Investing Acitivies
-9.29K -501.79K -425K 0.00
Investing Cash Flow
-9.29K -661.8K -673K -1.73K
Debt Repayment
n/a n/a -290.83K n/a
Common Stock Repurchased
n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
n/a 646.00 -1.78M -1.62M
Financial Cash Flow
4.65M 10.68M 15.07M 10.85M
Net Cash Flow
-2.34M 2.74M -1.19M 1.56M
Free Cash Flow
-7M -7.45M -15.62M -9.79M